| 书目名称 | Targeted Therapies in Lung Cancer: Management Strategies for Nurses and Practitioners |
| 编辑 | Marianne Davies,Beth Eaby-Sandy |
| 视频video | http://file.papertrans.cn/901/900627/900627.mp4 |
| 概述 | Very first book directed to nursing.Informs on how driver mutations drive treatment decisions in NSCLC and the application to care of patients.Provide nurses with the tools to educate patients about h |
| 图书封面 |  |
| 描述 | .This book aims to educate nurses and advanced practice providers (APP’s) about known mutations, availability of targeted therapy and the management of patients with non-small cell lung cancer (NSCLC). It will educate nurses and practitioners about the scope of therapy to assure safe and effective lung cancer treatment. In this era of personalized medicine, nurses and APP’s are responsible for guiding patients from diagnosis through treatment. This starts with the identification of patients that can benefit from these therapies, the key role of biopsy acquisition (ie. what to test, when and how often) and treatment selection based on the mutation identified. Readers will learn about the mechanisms of action, administration, potential adverse side effects and unique management strategies for these targeted agents. .Lung cancer continues to be the leading cause of cancer death in the United States and worldwide. Recent advances in the identification of specific oncogenic mutations that drive cancer development, growth and metastasis have led to major paradigm shifts in lung cancer treatment. Sophisticated methods are required to identify specific mutations at the time of diagnosis. |
| 出版日期 | Book 2019 |
| 关键词 | Lung cancer driver mutations; EGFR mutation; ALK translocation; Dermatologic toxicity; Oral cancer thera |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-030-16550-5 |
| isbn_softcover | 978-3-030-16552-9 |
| isbn_ebook | 978-3-030-16550-5 |
| copyright | Springer Nature Switzerland AG 2019 |
|Archiver|手机版|小黑屋|
派博传思国际
( 京公网安备110108008328)
GMT+8, 2025-8-17 15:13
发表于 2025-3-21 17:05:42
